Darbecure 60mcg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Darbepoetin alfa (60mcg)
Overview Darbecure 60mcg Injection
Erythropoietin (60mcg) injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. This medication necessitates careful administration due to potential serious adverse reactions; expert medical supervision is crucial. Strict adherence to physician instructions is mandatory. Administration occurs under healthcare professional oversight. Common side effects encompass abdominal discomfort, hypertension, skin rashes, injection site pain, dyspnea, cough, and peripheral edema. Report symptoms of severe hypertension, including intense headache, visual disturbances, nausea, vomiting, or convulsions immediately. Regular blood tests monitoring electrolyte (potassium) levels, hemoglobin, and blood cell counts are typically conducted. Discontinue use and consult a physician if shortness of breath or a skin rash develops. Prior to treatment, disclose any history of cardiac disease, hypertension, seizures, or stroke. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals should consult their doctor regarding the medication's safety profile.
Uses of Darbecure 60mcg Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Darbecure 60mcg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Darbecure 60mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbecure 60mcg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Darbecure 60mcg Injection works:
Darbepoetin alfa 60mcg injection promotes red blood cell production. This erythropoiesis-stimulating agent (ESA) acts by increasing red blood cell formation within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Darbecure 60mcg Injection with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darbecure 60mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Darbecure 60mcg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Darbecure 60mcg Injection.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Darbecure 60mcg Injection poses no safety concerns. No dosage modification is advised for Darbecure 60mcg Injection in this population.
LiverCAUTION
Caution is advised when administering 60mcg Darbecure injections to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Darbecure 60mcg Injection :
Should you forget a Darbecure 60mcg Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Darbecure 60mcg Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Erythropoietin-stimulating drug |
3,018 People bought this recently